Browsing by Author "Appel, Lawrence J"

Now showing 1 - 4 of 4
  • Thumbnail Image
    ItemOpen Access
    Application of Latent Class Analysis to Identify Behavioral Patterns of Response to Behavioral Lifestyle Interventions in Overweight and Obese Adults
    (International Journal of Behavioral Medicine, 2015-08) Fitzpatrick, Stephanie L; Coughlin, Janelle W; Appel, Lawrence J; Tyson, Crystal; Stevens, Victor J; Jerome, Gerald J; Dalcin, Arlene; Brantley, Phillip J; Hill-Briggs, Felicia
  • Thumbnail Image
    ItemOpen Access
    Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: The PREMIER study
    (American Journal of Kidney Diseases, 2013-11-01) Chang, Alex; Batch, Bryan C; McGuire, Heather L; Vollmer, William M; Svetkey, Laura P; Tyson, Crystal C; Sanguankeo, Anawin; Anderson, Cheryl; Houston, Jessica; Appel, Lawrence J
    Background: Excess adiposity and dietary factors may be important determinants of urinary albumin excretion (UAE). Study Design: Observational analysis of PREMIER, a randomized trial designed to lower blood pressure using behavioral interventions (counseling on weight loss, healthy diet, and exercise). Setting & Participants: 481 participants with normal kidney function who provided adequate 24-hour urine collections at baseline and 6 months. Predictors: Change in waist circumference; 24-hour urine sodium, potassium, and phosphorus excretion; and protein intake estimated from urea nitrogen. Outcomes & Measurements: The primary outcome was change in log-transformed 24-hour UAE over 6 months. Results: After 6 months, the proportion of individuals with UAE ≥10 mg/d decreased from 18.7% to 12.7% (P < 0.001). Changes in mean waist circumference (-4.2 ± 6.6 [SD] cm), 24-hour excretion of sodium (-28.2 ± 71.7 mmol/d), potassium (+8.4 ± 27.8 mmol/d), phosphorus (-27.7 ± 314.1 mg/d), and protein intake (-1.7 ± 19.4 g/d) were observed. After adjustment for relevant covariates, the following variables were associated significantly with reduction in ln(UAE) in separate models: decrease in waist circumference (P = 0.001), decrease in 24-hour urine phosphorus excretion (P < 0.001), and decrease in protein intake (P = 0.01). In a multivariable model including these 3 predictors, decreases in waist circumference (P = 0.002) and 24-hour urine phosphorus excretion (P = 0.03), but not change in protein intake (P = 0.5), remained associated significantly with reduction in ln(UAE). These associations remained significant even after adjustment for changes in blood pressure and insulin resistance. Baseline UAE and metabolic syndrome modified the relationship of waist circumference with ln(UAE); specifically, individuals with higher UAE and baseline metabolic syndrome experienced greater reductions in ln(UAE) from decreases in waist circumference. Limitations: Observational study with potential for confounding. Conclusions: In adults with normal kidney function, decreases in waist circumference and 24-hour urine phosphorus excretion are associated with reductions in UAE. These findings support the rationale for clinical trials to determine whether reducing dietary phosphorus intake or waist circumference could prevent chronic kidney disease or slow its progression. © 2013 National Kidney Foundation, Inc.
  • Thumbnail Image
    ItemOpen Access
    Impact of 5-year weight change on blood pressure: Results from the weight loss maintenance trial
    (Journal of Clinical Hypertension, 2013) Tyson, Crystal C; Appel, Lawrence J; Vollmer, William M; Jerome, Gerald J; Brantley, Phillip J; Hollis, Jack F; Stevens, Victor J; Ard, Jamy D; Patel, Uptal D; Svetkey, Laura P
    In this secondary analysis of the Weight Loss Maintenance trial, the authors assessed the relationship between blood pressure (BP) change and weight change in overweight and obese adults with hypertension and/or dyslipidemia who were randomized to 1 of 3 weight loss maintenance strategies for 5 years. The participants were grouped (N=741) based on weight change from randomization to 60 months as: (1) weight loss, (2) weight stable, or (3) weight gain. A significant positive correlation between weight change and systolic BP (SBP) change at 12, 30, and 60 months and between weight change and diastolic BP (DBP) change at 30 months was observed. From randomization to 60 months, mean SBP increased to a similar degree for the weight gain group (4.2±standard error=0.6 mm Hg; P<.001) and weight stable group (4.6±1.1 mm Hg; P<.001), but SBP did not rise in the weight loss group (1.0±1.7 mm Hg, P=53). DBP was unchanged for all groups at 60 months. Although aging may have contributed to rise in BP at 60 months, it does not appear to fully account for observed BP changes. These results suggest that continued modest weight loss may be sufficient for long-term BP lowering. © 2013 Wiley Periodicals, Inc.
  • Thumbnail Image
    ItemOpen Access
    Report of the National Heart, Lung, and Blood Institute Working Group on Hypertension: Barriers to Translation.
    (Hypertension (Dallas, Tex. : 1979), 2020-04) Sigmund, Curt D; Carey, Robert M; Appel, Lawrence J; Arnett, Donna K; Bosworth, Hayden B; Cushman, William C; Galis, Zorina S; Green Parker, Melissa; Hall, John E; Harrison, David G; McDonough, Alicia A; Nicastro, Holly L; Oparil, Suzanne; Osborn, John W; Raizada, Mohan K; Wright, Jacqueline D; Oh, Young S
    The National Heart, Lung, and Blood Institute convened a multidisciplinary working group of hypertension researchers on December 6 to 7, 2018, in Bethesda, MD, to share current scientific knowledge in hypertension and to identify barriers to translation of basic into clinical science/trials and implementation of clinical science into clinical care of patients with hypertension. The goals of the working group were (1) to provide an overview of recent discoveries that may be ready for testing in preclinical and clinical studies; (2) to identify gaps in knowledge that impede translation; (3) to highlight the most promising scientific areas in which to pursue translation; (4) to identify key challenges and barriers for moving basic science discoveries into translation, clinical studies, and trials; and (5) to identify roadblocks for effective dissemination and implementation of basic and clinical science in real-world settings. The working group addressed issues that were responsive to many of the objectives of the National Heart, Lung, and Blood Institute Strategic Vision. The working group identified major barriers and opportunities for translating research to improved control of hypertension. This review summarizes the discussion and recommendations of the working group.